Pain control by targeting oxidized phospholipids: functions, mechanisms, perspectives
Within the lipidome oxidized phospholipids (OxPL) form a class of chemically highly reactive metabolites. OxPL are acutely produced in inflamed tissue and act as endogenous, pain-inducing metabolites. They excite sensory, nociceptive neurons by activating transient receptor potential ion channels, s...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
25 January 2021
|
| In: |
Frontiers in endocrinology
Year: 2021, Volume: 11, Pages: 1-9 |
| ISSN: | 1664-2392 |
| DOI: | 10.3389/fendo.2020.613868 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3389/fendo.2020.613868 Verlag, lizenzpflichtig, Volltext: https://www.frontiersin.org/articles/10.3389/fendo.2020.613868/full 
|
| Author Notes: | Beatrice Oehler, Alexander Brack, Robert Blum and Heike L. Rittner |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1751131424 | ||
| 003 | DE-627 | ||
| 005 | 20220819133338.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210311s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3389/fendo.2020.613868 |2 doi | |
| 035 | |a (DE-627)1751131424 | ||
| 035 | |a (DE-599)KXP1751131424 | ||
| 035 | |a (OCoLC)1341398435 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Oehler, Beatrice |d 1985- |e VerfasserIn |0 (DE-588)1036470121 |0 (DE-627)751076732 |0 (DE-576)384398979 |4 aut | |
| 245 | 1 | 0 | |a Pain control by targeting oxidized phospholipids |b functions, mechanisms, perspectives |c Beatrice Oehler, Alexander Brack, Robert Blum and Heike L. Rittner |
| 264 | 1 | |c 25 January 2021 | |
| 300 | |a 9 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 01.12.2021 | ||
| 520 | |a Within the lipidome oxidized phospholipids (OxPL) form a class of chemically highly reactive metabolites. OxPL are acutely produced in inflamed tissue and act as endogenous, pain-inducing metabolites. They excite sensory, nociceptive neurons by activating transient receptor potential ion channels, specifically TRPA1 and TRPV1. Under inflammatory conditions, OxPL-mediated receptor potentials even potentiate the action potential firing rate of nociceptors. Targeting OxPL with D-4F peptide or antibodies like E06 can be used to control acute, inflammatory pain syndromes. The basics of how OxPL operate as agonists and excitants are not completely understood: Due to the difficulties to stabilize and measure these highly reactive metabolites in a physiological context, it is not yet clear, how OxPL contribute to the many functions of the epilipidome in vivo. With a focus on proalgesic specificities of OxPL, this article discusses, how targeting defined substances of the lipidome can contribute to mechanism-based therapies against primary and secondary chronic inflammatory or possibly also neuropathic pain. | ||
| 650 | 4 | |a Analgesia | |
| 650 | 4 | |a ion channel | |
| 650 | 4 | |a Mimetic peptide | |
| 650 | 4 | |a Nociception | |
| 650 | 4 | |a Oxidized phospholipids | |
| 650 | 4 | |a pain therapy | |
| 650 | 4 | |a therapeutic antibody | |
| 650 | 4 | |a TRP Channel | |
| 773 | 0 | 8 | |i Enthalten in |t Frontiers in endocrinology |d Lausanne : Frontiers Research Foundation, 2010 |g 11(2021), Artikel-ID 613868, Seite 1-9 |h Online-Ressource |w (DE-627)645090948 |w (DE-600)2592084-4 |w (DE-576)336962975 |x 1664-2392 |7 nnas |a Pain control by targeting oxidized phospholipids functions, mechanisms, perspectives |
| 773 | 1 | 8 | |g volume:11 |g year:2021 |g elocationid:613868 |g pages:1-9 |g extent:9 |a Pain control by targeting oxidized phospholipids functions, mechanisms, perspectives |
| 856 | 4 | 0 | |u https://doi.org/10.3389/fendo.2020.613868 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.frontiersin.org/articles/10.3389/fendo.2020.613868/full |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20210311 | ||
| 993 | |a Article | ||
| 994 | |a 2021 | ||
| 998 | |g 1036470121 |a Oehler, Beatrice |m 1036470121:Oehler, Beatrice |d 910000 |d 910300 |e 910000PO1036470121 |e 910300PO1036470121 |k 0/910000/ |k 1/910000/910300/ |p 1 |x j | ||
| 999 | |a KXP-PPN1751131424 |e 3884774379 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["eng"],"note":["Gesehen am 01.12.2021"],"physDesc":[{"extent":"9 S."}],"relHost":[{"title":[{"title":"Frontiers in endocrinology","title_sort":"Frontiers in endocrinology"}],"titleAlt":[{"title":"Bone Research"},{"title":"Cancer Endocrinology"},{"title":"Cellular Endocrinology"},{"title":"Diabetes"},{"title":"Endocrinology of Aging"},{"title":"Experimental Endocrinology"},{"title":"Genomic Endocrinology"},{"title":"Molecular and Structural Endocrinology"},{"title":"Neuroendocrine Science"},{"title":"Pediatric Endocrinology"},{"title":"Pituitary Endocrinology"},{"title":"Systems and Translational Endocrinology"},{"title":"Thyroid Endocrinology"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"part":{"pages":"1-9","year":"2021","text":"11(2021), Artikel-ID 613868, Seite 1-9","extent":"9","volume":"11"},"pubHistory":["1.2010 -"],"id":{"issn":["1664-2392"],"eki":["645090948"],"zdb":["2592084-4"]},"recId":"645090948","language":["eng"],"disp":"Pain control by targeting oxidized phospholipids functions, mechanisms, perspectivesFrontiers in endocrinology","physDesc":[{"extent":"Online-Ressource"}],"note":["Gesehen am 12.12.19","Specialty sections: Bone Research; Cancer Endocrinology; Cellular Endocrinology; Diabetes; Endocrinology of Aging; Experimental Endocrinology; Genomic Endocrinology; Molecular and Structural Endocrinology; Neuroendocrine Science; Pediatric Endocrinology; Pituitary Endocrinology; Systems and Translational Endocrinology; Thyroid Endocrinology"],"origin":[{"dateIssuedKey":"2010","publisher":"Frontiers Research Foundation","dateIssuedDisp":"2010-","publisherPlace":"Lausanne"}]}],"origin":[{"dateIssuedKey":"2021","dateIssuedDisp":"25 January 2021"}],"title":[{"title":"Pain control by targeting oxidized phospholipids","subtitle":"functions, mechanisms, perspectives","title_sort":"Pain control by targeting oxidized phospholipids"}],"person":[{"role":"aut","given":"Beatrice","roleDisplay":"VerfasserIn","display":"Oehler, Beatrice","family":"Oehler"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"name":{"displayForm":["Beatrice Oehler, Alexander Brack, Robert Blum and Heike L. Rittner"]},"recId":"1751131424","id":{"eki":["1751131424"],"doi":["10.3389/fendo.2020.613868"]}} | ||
| SRT | |a OEHLERBEATPAINCONTRO2520 | ||